Analyst Research

Report Title Price
Provider: S&P Capital IQ Factual Report
$138.00
Provider: GlobalData
$250.00
Provider: Plunkett Research, Ltd.
$99.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ventripoint Diagnostics Ltd announces closing of first tranche of private placement and shares for debt


Monday, 23 Jun 2014 07:00am EDT 

Ventripoint Diagnostics Ltd:Completes first tranche of private placement of 24,951,426 units for gross proceeds of $1,996,114.Each unit is comprised of one common share and one half of one common share purchase warrant.Each full Warrant is exercisable into one additional Common Share at an exercise price of $0.12 until June 20, 2016.Private Placement was about 33 pct non-brokered and 67 pct brokered, with D&D Securities Inc. acting as agent of corporation in brokered portion of private placement.Corporation will use proceeds for sales and marketing and general working capital purposes.Three of subscribers in the private placement accepted units as payment in full of outstanding secured debentures previously issued by the corporation as a shares-for-debt transaction.As a result of shares for debt, the corporation's net debt has been reduced by $773,626. 

Company Quote

0.06
 --
26 Nov 2014